Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Total Revenue (USD Million) (2018-2019)    Table 10. Table 49. Copyright © 2021 MarketWatch, Inc. All rights reserved. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Major Business. Astellas Pharma revenue for the twelve months ending September 30, 2020 was $5.895B, … Top pharmaceutical companies with revenue over $10 billion. Cookie Notice (). Statista. Astellas Pharma Treatmet of Dermatophytosis Product and Solutions. Astellas Pharma Europe B.V. has 544 total employees across all of its locations and generates $499.88 million in sales (USD). In depth view into Astellas Pharma Revenue (TTM) including historical data from 2008, charts, stats and industry comps. Find the latest ASTELLAS PHARMA (ALPMY) stock quote, history, news and other vital information to help you with your stock trading and investing. As a Premium user you get access to background information and details about the release of this statistic. Facebook: number of monthly active users worldwide 2008-2020, Smartphone market share worldwide by vendor 2009-2020, Number of apps available in leading app stores 2020, Profit from additional features with an Employee Account. Astellas Pharma Bipolar Forceps and Microscissors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 88. Astellas Pharma, Inc. Corporate Information, Location and Competitors. and CEO of Astellas is to overcome the impact on business performance due to the expiration of patents for these products and return Astellas to a growth trajectory. Find out the revenue, expenses and profit or loss over the last fiscal year. Learn more about how Statista can support your business. Astellas Pharma reported revenue of USD 12.267 billion for the FY 2018 which saw an increase of 4.75% compared to FY 2017. Please authenticate by going to "My account" → "Administration". Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. PR Team Zeal Insider January 18, 2021 218 Visit a quote page and your recently viewed tickers will be displayed here. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. See ASTELLAS PHARMA (4503.T) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Historical and current end-of-day data provided by FACTSET. This feature is limited to our corporate solutions. For the best MarketWatch.com experience, please update to a modern browser. This browser is no longer supported at MarketWatch. Oct 18, 2019 To enable deeper stakeholder understanding of Astellas' efforts to continue to create value for sustainable growth, we have published the annual report as an integrated report. Astellas Pharma, Inc. Cholera Vaccines Major Business. In the fiscal year 2019, the sales revenue of Astellas Pharma Inc. in the United States amounted to approximately 443.5 billion Japanese yen, making up the largest sales revenue. Available to download in PNG, PDF, XLS format, Access to this and all other statistics on 80,000 topics from, fiscal year 2010 to 2019; the company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year. Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product and Services You only have access to basic statistics. Astellas Pharma Inc. SWOT Analysis. Create a list of the investments you want to track. Astellas Pharma Treatmet of Dermatophytosis Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 36. As a Premium user you get access to the detailed source references and background information about this statistic. This statistic is not included in your account. GLOBAL WEBSITE. Astellas Pharma Main Business Table 89. New, Figures and insights about the advertising and media world, Industry Outlook Table 86. September 30, 2020. Corporate solution including all features. I want to retire in a college town with warm weather and lower taxes — where should I go. There are currently no items in this Watchlist. 2016 2017 2018 2019 2020 5-year trend; Sales/Revenue 1.37T: 1.31T: 1.3T: 1.31T: 1.3T Overview and forecasts on trending topics, Key figures and rankings about brands and companies, Consumer insights and preferences in various industries, Detailed information about political and social topics, All key figures about regions and countries, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Technology Market Outlook    Table 11. Astellas Pharma revenue grew at a CAGR of 2.77% during FY 2013 to FY 2018. Privacy Notice, and Directly accessible data for 170 industries from 50 countries Have Watchlists? Table 32. Figure Astellas Pharma Chronic Lung Diseases Treatment Business Revenue Market Share in 2018 Table Dr. Reddy's Laboratories Basic Information List Table Chronic Lung Diseases Treatment Business Revenue (Million USD) of Dr. Reddy's Laboratories (2014-2019) Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Click here for more Astellas locations There are 176 companies in the Astellas Pharma Europe B.V. corporate family. Important Notice. VAT rate on prescription-only drugs in Europe 2020, Market share of generics in European countries 2018, Research and development in European pharmaceutical industry by country 2018, Employment in European pharmaceutical industry by country 2018. - Revenue increased by 2.4%, excluding the negative impact of exchange rates with respect to yen appreciation. In depth view into Astellas Pharma Revenue (Quarterly) including historical data from 2008, charts, stats and industry comps. Astellas. Quick Analysis with our professional Research Service: Content Marketing & Information Design for your projects: Industry-specific and extensively researched technical data (partially from exclusive partnerships). Register in seconds and access exclusive features. Please create an employee account to be able to mark statistics as favorites. You need a Single Account for unlimited access. All quotes are in local exchange time. Then you can access your favorite statistics via the star in the header. Astellas Pharma Atopic Dermatitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 69. Accessed March 14, 2021. https://www.statista.com/statistics/825549/astellas-pharma-sales-value/, Astellas. Financial Results, Strategic Plan and other Investment relation news. This revenue is expected to increase by 1% and reach USD 12.39 billion by FY 2019. Revenue of Astellas Pharma Inc. from fiscal year 2010 to 2019 (in billion Japanese yen) [Graph]. "Revenue of Astellas Pharma Inc. from fiscal year 2010 to 2019 (in billion Japanese yen)." As soon as this statistic is updated, you will immediately be notified via e-mail. The patent cliff is an issue that we cannot avoid as long as we remain specialized in Astellas Pharma Inc. The revenue of Astellas Pharma Inc. in the fiscal year 2019 amounted to approximately 1.3 trillion Japanese yen, representing a slight decrease from around 1.37 trillion yen in fiscal 2015. Astellas Pharma Atopic Dermatitis Treatment Product and Solutions. Astellas Pharma Inc. Astellas Pharma Latest Developments Table 90. Get the detailed quarterly/annual income statement for ASTELLAS PHARMA (ALPMF). Figures up to fiscal year ended March 31 2014, are based on Japanese generally accepted accounting principles (J-GAAP). Product Sales: $4.1 Billion* (FY 2019) *Accurate as of April 2020. Update, Insights into the world's most important technology markets, Advertising & Media Outlook All values JPY millions. (September 30, 2020). The revenue of Astellas Pharma Inc. in the fiscal year 2019 amounted to approximately 1.3 trillion Japanese yen, representing a slight decrease from around 1.37 trillion yen in fiscal 2015. Subscriber Agreement & Terms of Use, Global Atopic Dermatitis Treatment Revenue (USD Million) by … Astellas Pharma SWOT Analysis. Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Astellas Pharma Europe B.V. is located in Leiden, ZUID-HOLLAND, Netherlands and is part of the Pharmaceutical Manufacturing Industry. Find out the revenue, expenses and profit or loss over the last fiscal year. In order to provide timely information, from FY2019, we have … Profit from additional features by authenticating your Admin account. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. ANNUAL REPORT 2018 Please contact us to get started with full access to dossiers, forecasts, studies and international data. Table 68. In, Astellas. U.S. Something went wrong while loading Watchlist. You need at least a Single Account to use this feature. - Sales of main products XTANDI for … New, Everything you need to know about the industry development, Find studies from all around the internet. By using this site you agree to the 1 Japanese yen equals 0.0096 U.S. dollars or 0.0082 euros as of November 2020. Table 67. Get the detailed quarterly/annual income statement for ASTELLAS PHARMA (ALPMY). Established in 1923, Astellas is a Japanese company operating in the business of manufacturing, marketing, and trade of pharmaceuticals. Then you will be able to mark statistics as favourites and use personal statistics alerts. Rank Chg Company 2020 USD billions 2019 USD billions 2018 USD billions 2017 USD billions 2016 USD billions 2015 USD billions 2014 USD billions 2013 USD billions 2012 ... Astellas Pharma TYO: … Astellas Pharma Bipolar Forceps and Microscissors Product Offered Table 87. A paid subscription is required for full access. facts. The Focus Area, where we put our efforts, consists of combinations of three components: 1) biology, 2) modality/technology, 3) diseases. Are you interested in testing our corporate solutions? In depth view into Astellas Pharma Revenue (Quarterly) including historical data from 2008, charts, stats and industry comps.    Table 9. Intraday Data provided by FACTSET and subject to terms of use. Table 46. Table 35. Intraday data delayed at least 15 minutes or per exchange requirements. Impact of Covid-19 on DNA Vaccination Market 2020-2028 – Inovio Pharmaceuticals, Merck, Astellas Pharma, Pfizer, etc. "Revenue of Astellas Pharma Inc. from Fiscal Year 2010 to 2019 (in Billion Japanese Yen). Astellas Pharma is one of the largest prescription drug companies in Japan. Log in to see them here or sign up to get started. Fiscal year is April-March. Find out all the key statistics for ASTELLAS PHARMA (ALPMY), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Astellas Pharma Inc. has adopted International Financial Reporting Standards (IFRS) since the fiscal year ended March 31, 2014. ", Astellas, Revenue of Astellas Pharma Inc. from fiscal year 2010 to 2019 (in billion Japanese yen) Statista, https://www.statista.com/statistics/825549/astellas-pharma-sales-value/ (last visited March 14, 2021), Revenue of Astellas Pharma Inc. from fiscal year 2010 to 2019, Revenue of leading European pharmaceutical markets 2019, Revenue of pharmaceutical markets in Central and Eastern Europe 2019, Pharmaceutical price structure breakdown in Europe 2018, VAT rate on over-the-counter drugs in Europe 2020, by country, European Union: share of GDP expenditure on research and development 2000-2018, Yearly growth rate of R&D spending in pharmaceutical industry 2005-2019, Leading 18 European pharmaceutical companies by retail sales 2018, Leading European pharmaceutical companies by R&D spending 2018, Members of EFPIA's pharmaceutical production value 1990-2019, Members of EFPIA's pharmaceutical R&D spending 1990-2019, Self-medication market sales in Europe in 2017, by country, Self-medication market sales of analgesics in Europe in 2017, by country, Cough and cold self-medication market sales in Europe in 2017, Digestives and intestinal remedies self-medication market sales in Europe 2017, Self-medication skin treatment product sales in Europe 2017, by country, Self-medication: sales of vitamins and minerals in Europe 2017, Market value of self-medication drugs in Italy 2014-2017, Sales revenue of self-care medicines in the Netherlands 2019, by purchase channel, Employment in EFPIA pharmaceutical industry 1990-2019, Pharmaceutical manufacturing employment in the United Kingdom 2008-2018, Switzerland: number of employees in biotech companies 2015-2019, Pharmaceutical industry: number of employees in Germany 2010-2018, Number of employees in the pharmaceutical industry in Belgium 2014-2019, Number of employees of pharmaceutical companies by region France 2018, Number of employees in the pharmaceutical industry in Italy 2000-2019, Distribution of European clinical and phase III pipeline 2013 by indication, Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011, Patients in clinical trials in selected European countries 2005-2011, Clinical trial conduct applications in Germany 2009-2019, Number of clinical trials authorized in Italy 2000-2019, Astellas Pharma's R&D expenditure FY 2010-2019, Astellas Pharma's operating profit FY 2010-2019, Astellas Pharma's net profit FY 2008-2017, Italy: international turnover of leading pharmaceutical companies 2007-2017, Italy: R&D investments of leading pharmaceutical companies 2007-2017, Consolidated net profit of the Ipsen group 2014-2019, Italy: perception of pharmaceutical companies 2018, by brand, Pharmaceutical industry settlements number - state and federal governments 1991-2015, Top pharmaceutical companies in Argentina 2014 by revenue, Ad spend of women's health products in the U.S. 2015, Market size osteoporosis drug market Japan 2014-2024, Worldwide generic pharmaceutical M&A deal value 2007-2015, Expected impact of Brexit on attractiveness of pharmaceutical market in the UK 2018, Revenue of Astellas Pharma Inc. from fiscal year 2010 to 2019 (in billion Japanese yen), Find your information in our database containing over 20,000 reports, Tools and Tutorials explained in our Media Centre.
Fisher-price Lama Waschen, Carl-von-ossietzky-schule Lehrer Corona, Astrazeneca Costa Rica, Amerikanische Kleidung Marken, Kulmbacher Brauerei Ag, Corona Testzentrum Rheda-wiedenbrück öffnungszeiten, Mizuno Wave Mirage Damen, Erima Trikot Leichtathletik, Indien Kühe Anzahl, Schwarzer Kuss Hörbuch, Motorische Entwicklung Kindergarten,